HK1166504A1 - Method for producing olmesartan medoxomil - Google Patents

Method for producing olmesartan medoxomil

Info

Publication number
HK1166504A1
HK1166504A1 HK12107211.4A HK12107211A HK1166504A1 HK 1166504 A1 HK1166504 A1 HK 1166504A1 HK 12107211 A HK12107211 A HK 12107211A HK 1166504 A1 HK1166504 A1 HK 1166504A1
Authority
HK
Hong Kong
Prior art keywords
olmesartan medoxomil
producing olmesartan
producing
medoxomil
olmesartan
Prior art date
Application number
HK12107211.4A
Other languages
English (en)
Chinese (zh)
Inventor
Shigeo Yanagihara
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43032158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1166504(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1166504A1 publication Critical patent/HK1166504A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12107211.4A 2009-04-28 2012-07-23 Method for producing olmesartan medoxomil HK1166504A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009109159 2009-04-28
PCT/JP2010/057403 WO2010126013A1 (ja) 2009-04-28 2010-04-27 オルメサルタンメドキソミルの製造方法

Publications (1)

Publication Number Publication Date
HK1166504A1 true HK1166504A1 (en) 2012-11-02

Family

ID=43032158

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12107211.4A HK1166504A1 (en) 2009-04-28 2012-07-23 Method for producing olmesartan medoxomil

Country Status (12)

Country Link
US (1) US8933241B2 (xx)
EP (1) EP2426126B1 (xx)
JP (1) JP5595383B2 (xx)
KR (1) KR101676512B1 (xx)
CN (1) CN102414200B (xx)
BR (1) BRPI1013333B8 (xx)
CA (1) CA2759163C (xx)
ES (1) ES2527686T3 (xx)
HK (1) HK1166504A1 (xx)
IL (1) IL215966A (xx)
TW (1) TWI539948B (xx)
WO (1) WO2010126013A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126014A1 (ja) * 2009-04-28 2010-11-04 第一三共株式会社 新規溶媒和物結晶
JP2014152127A (ja) * 2013-02-06 2014-08-25 Tokuyama Corp オルメサルタンメドキソミルの製造方法
CN103719825A (zh) * 2013-12-19 2014-04-16 芜湖佳诚电子科技有限公司 一种保健香菇粉及其制备方法
CN110082449B (zh) * 2019-05-24 2020-05-19 珠海润都制药股份有限公司 一种奥美沙坦酯中三苯基氯甲烷的检测方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0282519A (ja) 1988-09-19 1990-03-23 Sanyo Electric Co Ltd 固相エピタキシャル成長方法
US5616599A (en) 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2061607C (en) 1991-02-21 1999-01-19 Hiroaki Yanagisawa 1-biphenylimidazole derivatives, their preparation and their therapeutic use
JPH07121918A (ja) 1993-08-30 1995-05-12 Tdk Corp 光磁気記録媒体
JP3521304B2 (ja) 1996-03-21 2004-04-19 東洋化成工業株式会社 １−（テトラゾリルビフェニルメチル）イミダゾール誘導体の製造方法
JP3671266B2 (ja) 1996-03-21 2005-07-13 東洋化成工業株式会社 ５−置換テトラゾール類の製造方法
JP2004217542A (ja) 2003-01-10 2004-08-05 Fuji Photo Film Co Ltd ４，５−ジアルコキシカルボニルイミダゾールの製造方法
ATE398121T1 (de) 2003-01-16 2008-07-15 Teva Pharma Neue synthese von irbesartan
US20060074117A1 (en) * 2004-09-02 2006-04-06 Lilach Hedvati Purification of olmesartan medoxomil
US20070054948A1 (en) 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
US7528258B2 (en) 2004-09-02 2009-05-05 Teva Pharmaceutical Industries Ltd Preparation of olmesartan medoxomil
JP2006111586A (ja) 2004-10-15 2006-04-27 Nippon Petrochemicals Co Ltd 置換芳香族化合物の酸化方法
WO2006073519A1 (en) 2005-01-03 2006-07-13 Teva Pharmaceutical Industries Ltd. Olmesartan medoxomil with reduced levels of impurities
US7943779B2 (en) 2005-07-29 2011-05-17 Krka Process for the preparation of olmesartan medoxomil
SI22092A (sl) 2005-07-29 2007-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo olmesartan medoksomila
WO2007047838A2 (en) 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
CZ299902B6 (cs) 2005-10-27 2008-12-29 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv
WO2007148344A2 (en) 2006-06-19 2007-12-27 Matrix Laboratories Limited Process for the preparation of olmesartan medoxomil
ITMI20061848A1 (it) * 2006-09-27 2008-03-28 Dipharma Spa Procedimento per la preparazione di composti feniltetrazolici
KR101458369B1 (ko) * 2006-10-09 2014-11-05 씨아이피엘에이 엘티디. 트리틸 올메사탄 메독소밀 및 올메사탄 메독소밀의 제조방법
CN101778842B (zh) 2007-08-08 2014-10-29 力奇制药公司 制备或纯化奥美沙坦酯的方法
EP2036904A1 (en) 2007-08-08 2009-03-18 LEK Pharmaceuticals D.D. A process for the preparation of olmesartan medoxomil
ES2540062T3 (es) 2008-06-09 2015-07-08 Daiichi Sankyo Company, Limited Procedimiento de producción de un compuesto de 1-bifenilmetilimidazol
WO2010026255A1 (en) 2008-09-05 2010-03-11 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing olmesartan medoxomil intermediate
WO2011014611A2 (en) 2009-07-30 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of olmesartan medoxomil
EP2585441A4 (en) 2010-06-28 2013-10-09 Hetero Research Foundation PROCESS FOR OLMESARTAN MEDOXOMIL

Also Published As

Publication number Publication date
WO2010126013A1 (ja) 2010-11-04
BRPI1013333B1 (pt) 2020-10-20
EP2426126A1 (en) 2012-03-07
CN102414200B (zh) 2014-12-17
CN102414200A (zh) 2012-04-11
JPWO2010126013A1 (ja) 2012-11-01
KR20120006512A (ko) 2012-01-18
IL215966A0 (en) 2012-01-31
US20120071665A1 (en) 2012-03-22
TWI539948B (zh) 2016-07-01
IL215966A (en) 2014-01-30
US8933241B2 (en) 2015-01-13
ES2527686T3 (es) 2015-01-28
BRPI1013333A2 (pt) 2016-03-29
TW201043617A (en) 2010-12-16
CA2759163C (en) 2015-02-17
CA2759163A1 (en) 2010-11-04
BRPI1013333B8 (pt) 2021-05-25
KR101676512B1 (ko) 2016-11-15
EP2426126B1 (en) 2014-11-19
JP5595383B2 (ja) 2014-09-24
EP2426126A4 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
EP2463313A4 (en) METHOD FOR MANUFACTURING COPOLYMER
ZA201009116B (en) Method for producing microlenses
EP2415731A4 (en) METHOD FOR PRODUCING A SLUDGE COMPOSITION
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
PL2408834T3 (pl) Sposób wytwarzania kompozytów kserożelowych
EP2474560A4 (en) METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE
EP2309823A4 (en) METHOD OF MANUFACTURING THE DEVICE
EP2500451A4 (en) METHOD FOR PRODUCING A LAMINATE
EP2332421A4 (en) PROCESS FOR PRODUCING MODIFIED MILK
PL2432877T3 (pl) Metoda otrzymywania (+) -zizaenu
EP2399897A4 (en) METHOD FOR PRODUCING AN OXYGEN-CONTAINING COMPOUND
SI2334668T1 (sl) Postopek priprave intermediata olmesartan medoksomila
PL2491086T3 (pl) Metoda sklejania
EP2374789A4 (en) METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE
PL2440510T3 (pl) Sposób wytwarzania pentafluoropropanu
IL214287A0 (en) Method for producing 2-aminobiphenylene
EP2301901A4 (en) METHOD FOR PRODUCING A HYDRAULIC PULVER
EP2412712A4 (en) METHOD FOR PRODUCING AN EPOXY COMPOUND
EP2266943A4 (en) PROCESS FOR PRODUCING 2-ALKYL-2-CYCLOALCENE-1-ONE
EP2243755A4 (en) METHOD FOR MANUFACTURING A SINTERED BODY
PL2291434T3 (pl) Sposób wytwarzania polioli
EP2364963A4 (en) PROCESS AND PREPARATION OF OLEFIN
IL214362A0 (en) Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
IL210051A0 (en) Method for producing aminobiphenylene
EP2357247A4 (en) PROCESS FOR THE PRODUCTION OF POLY-3-HYDROXYALKANOATE